Pharma cartel, market abuses call for easier China market access to bolster competition, cabinet advisor says
China should consider easing access to its markets for active pharmaceutical ingredients to bolster competition, an antitrust advisor to the country's cabinet said. The remarks came after two drug makers were...To view the full article, register now.
Already a subscriber? Click here to view full article